Umantod, Baby Girl .
HRN: 27-27-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/22/2025
06/29/2025
IV
39mg
OD
PSNB
Waiting Final Action
Indication: Prophylaxis Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes